Amentum Holdings reports Q2 2026 earnings on May 12 with the stock already in retreat — and the debate among investors is less about short-seller pressure and more about whether the defense consultancy can rebuild confidence after a brutal prior-quarter reaction.
The price tells the most urgent story. AMTM has fallen 9% over the past month to $23.94, with a 7% drop in the last week alone. That momentum sits against a backdrop of a deeply unflattering reference point: last quarter's print drove a 17% single-day collapse and an 18% five-day loss — the steepest one-day reaction in the company's short public history. The RSI has compressed to 35.7, brushing oversold territory. Peers have also had a rough week — LDOS fell 13%, KBR dropped 13%, and HURN slid 9% — pointing to a sector-wide reset, though AMTM's 7% one-week decline keeps it roughly in line with that peer cohort rather than dramatically outperforming or underperforming it.
The short positioning heading into this print is measured, not aggressive. SI stands at 4.8% of free float — up 5% on the month but easing 3% on the week as some shorts covered. Borrow is effectively free at 0.47% cost to borrow, and the lending market is loose. The short score of 53.1 is middling and has been drifting lower over the past week. None of this signals a squeeze setup or a heavily committed short base. The money on the short side is present but not concentrated.
Options traders have turned notably more constructive relative to recent weeks. The put/call ratio has dropped to 0.37 — below its 20-day average of 0.39 and near the lower end of its observed range over the past year. That's a modest but clear shift toward calls, which contrasts with the caution visible in the price action. It may reflect positioning for a bounce after last quarter's de-rating, or simply reflect thin positioning overall in a stock that lacks the liquidity depth to generate heavily skewed options flow.
The analytical community remains supportive in target terms but has been quiet in recent weeks. The consensus mean target is around $36.50 — implying roughly 50% upside from current levels — but the most recent actions, all from Citizens reiterating a $40 Market Outperform target in mid-April, carry limited new information. Bulls point to Amentum's alignment with national security spending, its nuclear and digital infrastructure exposure, and potential margin gains from its post-merger integration. Bears flag execution risk on that same integration, key-person retention, heavy reliance on the Global Engineering Solutions segment for revenue, and the always-present hazard of government spending priority shifts. The P/E has compressed to 9.7x and EV/EBITDA to 8.5x — inexpensive multiples, but the prior quarter showed that cheap doesn't protect against a miss. Invesco's recent addition of 2.4 million shares to reach a 9% stake is the most notable institutional signal of confidence in the shareholder register, though that disclosure covers the April 30 period.
Today's print tests whether Amentum can post a quarter that closes the gap between a $23 stock price and a $36+ analyst consensus — or whether execution concerns from the February earnings will compound further.
See the live data behind this article on ORTEX.
Open AMTM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
